Dickinson, R, Raynor, DK orcid.org/0000-0003-0306-5275, Knapp, P et al. (1 more author) (2016) Do Patients Use a Headline Section in a Leaflet to Find Key Information About Their Medicines? Findings From a User-Test Study. Therapeutic Innovation & Regulatory Science, 50 (5). pp. 581-591. ISSN 2168-4790
Abstract
Background: In the European Union (EU), all medicines are mandated to be provided with a patient information leaflet (PIL). Many patients express concerns about the length and complexity of some PILs, and this can be a disincentive for patients to read the PILS. In order to address this, the UK’s regulatory body (Medicine and Healthcare products Regulatory Agency [MHRA]) suggested leaflets might include a headline section—information presented prominently at the beginning of a leaflet that summarizes key safety messages about a drug. Objective: To explore the extent to which readers used a headline section in a PIL, using a form of diagnostic testing called user-testing, which examines how readers find and understand key information. Methods: The study used a cross-sectional design to user-test a PIL with a headline section in a target sample of 20 participants. Participants were provided with an exemplar PIL, and the performance of the PIL was evaluated by a questionnaire and semistructured interview. Results: The results showed that a headline section was used just over one-third of the time (39%); 90% of participants used the headline section to find information when they initially began the user-test. The qualitative findings suggested that the participants valued the presence of the headline section. Conclusion: The research suggests there does not appear to be any negative impact from including a headline section in a PIL, and it is a technique that is highly valued by the consumers of medicines information.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2016 The Authors. This is an author produced version of a paper published in Therapeutic Innovation & Regulatory Science. Uploaded in accordance with the publisher's self-archiving policy. |
Keywords: | drug information; user-testing; patient information leaflet; headline section |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Healthcare (Leeds) > Nursing Adult (Leeds) The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Healthcare (Leeds) > Pharmacy (Leeds) |
Funding Information: | Funder Grant number Department of Health PO 3604 |
Depositing User: | Symplectic Publications |
Date Deposited: | 25 May 2016 12:45 |
Last Modified: | 05 Nov 2016 06:18 |
Published Version: | http://dx.doi.org/10.1177/2168479016639080 |
Status: | Published |
Publisher: | SAGE |
Identification Number: | 10.1177/2168479016639080 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:98493 |